Literature DB >> 3012529

Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene.

W G Tarpley, N K Hopkins, R R Gorman.   

Abstract

Recent studies have shown that the 21-kilodalton protein (p21) Ha-ras gene product shares sequence homology with and may exhibit biochemical properties similar to the mammalian guanine nucleotide-binding proteins. These data suggested that one of the biochemical functions of p21 in the vertebrate cell may be to regulate adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1]. We determined both in intact NIH-3T3 murine cells and in membranes isolated from these cells that the hormone-stimulated adenylate cyclase activity of cells expressing the EJ human bladder carcinoma oncogene (EJ-ras) is significantly reduced compared with control cells. Thus, the levels of cAMP measured in the EJ-ras-transformed cells by radioimmunoassay are reduced 78% and 93% after prostaglandin and isoproterenol stimulation, respectively, compared with the levels in control cells. Treatment of the EJ-ras-transformed cells with pertussis toxin or cholera toxin did not correct the alterations in adenylate cyclase activity. Cells expressing the normal human Ha-ras gene displayed intermediate levels of adenylate cyclase hormone sensitivity; these levels of adenylate cyclase activity were greater than those in the EJ-ras-transformed cells but lower than in control cells. Hormone-stimulated adenylate cyclase activities in cells transfected with Rous sarcoma virus DNA were similar to those in control cells. These data support the hypothesis that both the normal and mutated Ha-ras p21s are related to guanine nucleotide-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012529      PMCID: PMC323591          DOI: 10.1073/pnas.83.11.3703

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Altered adenylate cyclase activity: its role in growth regulation and malignant transformation of fibroblasts.

Authors:  W B Anderson; I Pastan
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

2.  Factors influencing the effect of hormones on the accumulation of cyclic AMP in cultured human astrocytoma cells.

Authors:  R B Clark; Y F Su; R Ortmann; L Cubeddu; G L Johnson; J P Perkins
Journal:  Metabolism       Date:  1975-03       Impact factor: 8.694

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.

Authors:  A L Steiner; C W Parker; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

6.  A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain.

Authors:  H Shimizu; J W Daly; C R Creveling
Journal:  J Neurochem       Date:  1969-12       Impact factor: 5.372

7.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

8.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

Authors:  J F Harper; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1975

9.  Mechanism of action of Vibrio cholerae enterotoxin. Effects on adenylate cyclase of toad and rat erythrocyte plasma membranes.

Authors:  V Bennett; P Cuatrecasas
Journal:  J Membr Biol       Date:  1975-06-03       Impact factor: 1.843

10.  Molecular cloning and characterization of avian sarcoma virus circular DNA molecules.

Authors:  W J DeLorbe; P A Luciw; H M Goodman; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

View more
  10 in total

1.  No evidence for the mutation of ras gene in psoriatic epidermis.

Authors:  H Takahashi; H Iizuka; M Katagiri
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.

Authors:  C W Benjamin; W G Tarpley; R R Gorman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

3.  Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene.

Authors:  A H Lin; V E Groppi; R R Gorman
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

4.  NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization.

Authors:  C W Benjamin; J A Connor; W G Tarpley; R R Gorman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

5.  Glucocorticoid and cAMP induction mechanisms are differentially affected by the p85gag-mos oncoprotein.

Authors:  B J Hamilton; D DeFranco
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  Forskolin inducibility and tissue-specific expression of the fibronectin promoter.

Authors:  D C Dean; M S Blakeley; R F Newby; P Ghazal; L Hennighausen; S Bourgeois
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

7.  Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

Authors:  B M Burgering; A J Snijders; J A Maassen; A J van der Eb; J L Bos
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

8.  Enhanced expression of ras gene products in psoriatic epidermis.

Authors:  H Kobayashi; H Yasuda; A Ohkawara; H Dosaka; A Oda; Y Ogiso; N Kuzumaki
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

9.  Deregulation of hamster fibroblast proliferation by mutated ras oncogenes is not mediated by constitutive activation of phosphoinositide-specific phospholipase C.

Authors:  K Seuwen; A Lagarde; J Pouysségur
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

10.  Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor beta, and cAMP in human cell lines.

Authors:  D C Dean; R F Newby; S Bourgeois
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.